Lead: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting cover art

Lead: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting

Lead: Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting

Listen for free

View show details

About this listen

Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting

JAMA Network Open

Injectable-only buprenorphine protocols are an exciting new strategy for buprenorphine initiation, particularly in the fentanyl era. This is a cohort study of 95 patients with moderate to severe opioid use disorder who received care in a low-threshold setting in Seattle. 79% of patients included in the study were experiencing homelessness or living in permanent supportive housing. Patients selected a long-acting injectable (LAI) buprenorphine initiation protocol which included three escalating doses of LAI buprenorphine over three days, with no sublingual buprenorphine and without cessation of fentanyl/opioid use. 75% of the patients completed the protocol, and 64% received a second monthly dose of LAI buprenorphine.

Read this issue of the ASAM Weekly

Subscribe to the ASAM Weekly

Visit ASAM
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.